Plasmacytoid dendritic cells in keratoacanthoma and squamous cell carcinoma: A blinded study of CD123 as a diagnostic marker.
Garth R FragaPeter ChowPublished in: Journal of cutaneous pathology (2019)
CD123 immunostaining is not a clinically useful test for distinguishing KA from SCC.